Table of Contents GBI Research Report Guidance 2 Executive Summary 3 Table of Contents 4 List of Tables 6 List of Figures 12 Introduction 14 Transplantation Report Coverage 14 Bone Marrow Transplant Rejection - Overview 14 Graft Versus Host Disease (GVHD) - Overview 14 Liver Transplant Rejection - Overview 14 Kidney Transplant Rejection - Overview 14 Lung Transplant Rejection - Overview 14 Heart Transplant Rejection - Overview 15 Therapeutics Development 16 Bone Marrow Transplant Rejection 16 Graft Versus Host Disease (GVHD) 27 Liver Transplant Rejection 38 Kidney Transplant Rejection 42 Lung Transplant Rejection 48 Heart Transplant Rejection 51 Therapeutics Assessment 52 Bone Marrow Transplant Rejection 52 Graft Versus Host Disease (GVHD) 62 Liver Transplant Rejection 72 Kidney Transplant Rejection 80 Lung Transplant Rejection 88 Heart Transplant Rejection 96 Companies Involved in Therapeutics Development 104 Bone Marrow Transplant Rejection 104 Graft Versus Host Disease (GVHD) 139 Liver Transplant Rejection 170 Kidney Transplant Rejection 173 Lung Transplant Rejection 185 Heart Transplant Rejection 187 Dormant Projects 189 Bone Marrow Transplant Rejection 189 Graft Versus Host Disease (GVHD) 192 Liver Transplant Rejection 195 Kidney Transplant Rejection 196 Lung Transplant Rejection 198 Heart Transplant Rejection 198 Discontinued Products 199 Bone Marrow Transplant Rejection 199 Graft Versus Host Disease (GVHD) 199 Liver Transplant Rejection 200 Kidney Transplant Rejection 200 Product Development Milestones 201 Bone Marrow Transplant Rejection 201 Graft Versus Host Disease (GVHD) 212 Liver Transplant Rejection 223 Kidney Transplant Rejection 225 Lung Transplant Rejection 234 Appendix 241 Methodology 241 Coverage 241 Secondary Research 241 Primary Research 241 Expert Panel Validation 241 Contact Us 241 Disclaimer 242

List of Tables Number of Products under Development for Bone Marrow Transplant Rejection 16 Number of Products under Development by Companies, Bone Marrow Transplant Rejection 18 Number of Products under Development by Universities/Institutes, Bone Marrow Transplant Rejection 21 Products under Development by Companies, Bone Marrow Transplant Rejection 22 Products under Development by Universities/Institutes, Bone Marrow Transplant Rejection 26 Number of Products under Development for Graft Versus Host Disease (GVHD) 27 Number of Products under Development by Companies, Graft Versus Host Disease (GVHD) 29 Number of Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD) 32 Products under Development by Companies, Graft Versus Host Disease (GVHD) 33 Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD) 37 Number of Products under Development for Liver Transplant Rejection 38 Number of Products under Development by Companies, Liver Transplant Rejection 39 Number of Products under Development by Universities/Institutes, Liver Transplant Rejection 40 Products under Development by Companies, Liver Transplant Rejection 41 Products under Development by Universities/Institutes, Liver Transplant Rejection 41 Number of Products under Development for Kidney Transplant Rejection 42 Number of Products under Development by Companies, Kidney Transplant Rejection 44 Number of Products under Development by Universities/Institutes, Kidney Transplant Rejection 45 Products under Development by Companies, Kidney Transplant Rejection 46 Products under Development by Universities/Institutes, Kidney Transplant Rejection 47 Number of Products under Development for Lung Transplant Rejection 48 Number of Products under Development by Companies, Lung Transplant Rejection 49 Products under Development by Companies, Lung Transplant Rejection 50 Number of Products under Development for Heart Transplant Rejection 51 Number of Products under Development by Companies, Heart Transplant Rejection 51 Products under Development by Companies, Heart Transplant Rejection 51 Number of Products by Stage and Target, Bone Marrow Transplant Rejection 53 Number of Products by Stage and Mechanism of Action, Bone Marrow Transplant Rejection 56 Number of Products by Stage and Route of Administration, Bone Marrow Transplant Rejection 59 Number of Products by Stage and Molecule Type, Bone Marrow Transplant Rejection 61 Number of Products by Stage and Target, Graft Versus Host Disease (GVHD) 63 Number of Products by Stage and Mechanism of Action, Graft Versus Host Disease (GVHD) 66 Number of Products by Stage and Route of Administration, Graft Versus Host Disease (GVHD) 69 Number of Products by Stage and Molecule Type, Graft Versus Host Disease (GVHD) 71 Number of Products by Stage and Target, Liver Transplant Rejection 73 Number of Products by Stage and Mechanism of Action, Liver Transplant Rejection 75 Number of Products by Stage and Route of Administration, Liver Transplant Rejection 77 Number of Products by Stage and Molecule Type, Liver Transplant Rejection 79 Number of Products by Stage and Target, Kidney Transplant Rejection 81 Number of Products by Stage and Mechanism of Action, Kidney Transplant Rejection 83 Number of Products by Stage and Route of Administration, Kidney Transplant Rejection 85 Number of Products by Stage and Molecule Type, Kidney Transplant Rejection 87 Number of Products by Stage and Target, Lung Transplant Rejection 89 Number of Products by Stage and Mechanism of Action, Lung Transplant Rejection 91 Number of Products by Stage and Route of Administration, Lung Transplant Rejection 93 Number of Products by Stage and Molecule Type, Lung Transplant Rejection 95 Number of Products by Stage and Target, Heart Transplant Rejection 97 Number of Products by Stage and Mechanism of Action, Heart Transplant Rejection 99 Number of Products by Stage and Route of Administration, Heart Transplant Rejection 101 Number of Products by Stage and Molecule Type, Heart Transplant Rejection 103 Bone Marrow Transplant Rejection - Pipeline by AbbVie Inc 104 Bone Marrow Transplant Rejection - Pipeline by AbGenomics International Inc 104 Bone Marrow Transplant Rejection - Pipeline by Actelion Ltd 105 Bone Marrow Transplant Rejection - Pipeline by Alexion Pharmaceuticals Inc 105 Bone Marrow Transplant Rejection - Pipeline by Allergan Plc 106 Bone Marrow Transplant Rejection - Pipeline by Amunix Operating Inc 106 Bone Marrow Transplant Rejection - Pipeline by AnaptysBio Inc 107 Bone Marrow Transplant Rejection - Pipeline by apceth Biopharma GmbH 107 Bone Marrow Transplant Rejection - Pipeline by Aptevo Therapeutics Inc 108 Bone Marrow Transplant Rejection - Pipeline by arGEN-X BV 108 Bone Marrow Transplant Rejection - Pipeline by Athersys Inc 109 Bone Marrow Transplant Rejection - Pipeline by Bellicum Pharmaceuticals Inc 109 Bone Marrow Transplant Rejection - Pipeline by Bio-Cancer Treatment International Ltd 110 Bone Marrow Transplant Rejection - Pipeline by Biogen Inc 110 Bone Marrow Transplant Rejection - Pipeline by Bristol-Myers Squibb Company 111 Bone Marrow Transplant Rejection - Pipeline by Cantex Pharmaceuticals Inc 111 Bone Marrow Transplant Rejection - Pipeline by Capricor Therapeutics Inc 112 Bone Marrow Transplant Rejection - Pipeline by Cell Source Inc 112 Bone Marrow Transplant Rejection - Pipeline by Cell2B Advanced Therapeutics SA 113 Bone Marrow Transplant Rejection - Pipeline by CellECT Bio Inc 113 Bone Marrow Transplant Rejection - Pipeline by Cleveland BioLabs Inc 114 Bone Marrow Transplant Rejection - Pipeline by Compugen Ltd 114 Bone Marrow Transplant Rejection - Pipeline by Cynata Therapeutics Limited 115 Bone Marrow Transplant Rejection - Pipeline by Cytodyn Inc 115 Bone Marrow Transplant Rejection - Pipeline by Dompe Farmaceutici SpA 116 Bone Marrow Transplant Rejection - Pipeline by Dr. Falk Pharma GmbH 116 Bone Marrow Transplant Rejection - Pipeline by Escape Therapeutics Inc 117 Bone Marrow Transplant Rejection - Pipeline by F. Hoffmann-La Roche Ltd 117 Bone Marrow Transplant Rejection - Pipeline by Fate Therapeutics Inc 118 Bone Marrow Transplant Rejection - Pipeline by Generon (Shanghai) Corp Ltd 118 Bone Marrow Transplant Rejection - Pipeline by Gilead Sciences Inc 119 Bone Marrow Transplant Rejection - Pipeline by GlaxoSmithKline Plc 119 Bone Marrow Transplant Rejection - Pipeline by Immunomedics Inc 120 Bone Marrow Transplant Rejection - Pipeline by Incyte Corp 120 Bone Marrow Transplant Rejection - Pipeline by Jazz Pharmaceuticals Plc 121 Bone Marrow Transplant Rejection - Pipeline by Kadmon Corp LLC 121 Bone Marrow Transplant Rejection - Pipeline by Kamada Ltd 122 Bone Marrow Transplant Rejection - Pipeline by Kiadis Pharma NV 122 Bone Marrow Transplant Rejection - Pipeline by Kymab Ltd 123 Bone Marrow Transplant Rejection - Pipeline by Kyorin Pharmaceutical Co Ltd 123 Bone Marrow Transplant Rejection - Pipeline by MacroGenics Inc 124 Bone Marrow Transplant Rejection - Pipeline by Mallinckrodt Plc 124 Bone Marrow Transplant Rejection - Pipeline by Medsenic 125 Bone Marrow Transplant Rejection - Pipeline by Mesoblast Ltd 125 Bone Marrow Transplant Rejection - Pipeline by Millennium Pharmaceuticals Inc 126 Bone Marrow Transplant Rejection - Pipeline by Nektar Therapeutics 126 Bone Marrow Transplant Rejection - Pipeline by Neovii Pharmaceuticals AG 127 Bone Marrow Transplant Rejection - Pipeline by Nohla Therapeutics Inc 127 Bone Marrow Transplant Rejection - Pipeline by Novartis AG 128 Bone Marrow Transplant Rejection - Pipeline by OncoImmune Inc 128 Bone Marrow Transplant Rejection - Pipeline by OSE Immunotherapeutics 129 Bone Marrow Transplant Rejection - Pipeline by Pfizer Inc 129 Bone Marrow Transplant Rejection - Pipeline by Pharmicell Co Ltd 130 Bone Marrow Transplant Rejection - Pipeline by Pluristem Therapeutics Inc 130 Bone Marrow Transplant Rejection - Pipeline by REGiMMUNE Corp 131 Bone Marrow Transplant Rejection - Pipeline by Sanofi 131 Bone Marrow Transplant Rejection - Pipeline by Sarepta Therapeutics Inc 132 Bone Marrow Transplant Rejection - Pipeline by Seattle Genetics Inc 132 Bone Marrow Transplant Rejection - Pipeline by Seres Therapeutics Inc 133 Bone Marrow Transplant Rejection - Pipeline by Sigmoid Pharma Ltd 133 Bone Marrow Transplant Rejection - Pipeline by Synedgen Inc 134 Bone Marrow Transplant Rejection - Pipeline by Taiga Biotechnologies Inc 134 Bone Marrow Transplant Rejection - Pipeline by Takeda Pharmaceutical Company Ltd 135 Bone Marrow Transplant Rejection - Pipeline by Targazyme Inc 135 Bone Marrow Transplant Rejection - Pipeline by United BioPharma Inc 136 Bone Marrow Transplant Rejection - Pipeline by Vault Pharma Inc 136 Bone Marrow Transplant Rejection - Pipeline by VBI Vaccines Inc 137 Bone Marrow Transplant Rejection - Pipeline by Xenikos BV 137 Bone Marrow Transplant Rejection - Pipeline by XL-protein GmbH 138 Bone Marrow Transplant Rejection - Pipeline by ZIOPHARM Oncology Inc 138 Graft Versus Host Disease (GVHD) - Pipeline by AbbVie Inc 139 Graft Versus Host Disease (GVHD) - Pipeline by AbGenomics International Inc 139 Graft Versus Host Disease (GVHD) - Pipeline by Allergan Plc 140 Graft Versus Host Disease (GVHD) - Pipeline by Amunix Operating Inc 140 Graft Versus Host Disease (GVHD) - Pipeline by AnaptysBio Inc 141 Graft Versus Host Disease (GVHD) - Pipeline by apceth Biopharma GmbH 141 Graft Versus Host Disease (GVHD) - Pipeline by Aptevo Therapeutics Inc 142 Graft Versus Host Disease (GVHD) - Pipeline by arGEN-X BV 142 Graft Versus Host Disease (GVHD) - Pipeline by Athersys Inc 143 Graft Versus Host Disease (GVHD) - Pipeline by Bellicum Pharmaceuticals Inc 143 Graft Versus Host Disease (GVHD) - Pipeline by Bio-Cancer Treatment International Ltd 144 Graft Versus Host Disease (GVHD) - Pipeline by Biogen Inc 144 Graft Versus Host Disease (GVHD) - Pipeline by Bristol-Myers Squibb Company 145 Graft Versus Host Disease (GVHD) - Pipeline by Capricor Therapeutics Inc 145 Graft Versus Host Disease (GVHD) - Pipeline by Cell2B Advanced Therapeutics SA 146 Graft Versus Host Disease (GVHD) - Pipeline by CellECT Bio Inc 146 Graft Versus Host Disease (GVHD) - Pipeline by Commence Bio Inc 147 Graft Versus Host Disease (GVHD) - Pipeline by Cynata Therapeutics Ltd 147 Graft Versus Host Disease (GVHD) - Pipeline by Cytodyn Inc 148 Graft Versus Host Disease (GVHD) - Pipeline by Dr. Falk Pharma GmbH 148 Graft Versus Host Disease (GVHD) - Pipeline by Escape Therapeutics Inc 149 Graft Versus Host Disease (GVHD) - Pipeline by F. Hoffmann-La Roche Ltd 149 Graft Versus Host Disease (GVHD) - Pipeline by Fate Therapeutics Inc 150 Graft Versus Host Disease (GVHD) - Pipeline by Generon (Shanghai) Corp Ltd 150 Graft Versus Host Disease (GVHD) - Pipeline by Gilead Sciences Inc 151 Graft Versus Host Disease (GVHD) - Pipeline by GlaxoSmithKline Plc 151 Graft Versus Host Disease (GVHD) - Pipeline by Incyte Corp 152 Graft Versus Host Disease (GVHD) - Pipeline by Jazz Pharmaceuticals Plc 152 Graft Versus Host Disease (GVHD) - Pipeline by Kadmon Corp LLC 153 Graft Versus Host Disease (GVHD) - Pipeline by Kamada Ltd 153 Graft Versus Host Disease (GVHD) - Pipeline by Kiadis Pharma NV 154 Graft Versus Host Disease (GVHD) - Pipeline by Kymab Ltd 154 Graft Versus Host Disease (GVHD) - Pipeline by Kyorin Pharmaceutical Co Ltd 155 Graft Versus Host Disease (GVHD) - Pipeline by MacroGenics Inc 155 Graft Versus Host Disease (GVHD) - Pipeline by Mallinckrodt Plc 156 Graft Versus Host Disease (GVHD) - Pipeline by Mesoblast Ltd 156 Graft Versus Host Disease (GVHD) - Pipeline by Millennium Pharmaceuticals Inc 157 Graft Versus Host Disease (GVHD) - Pipeline by Nektar Therapeutics 157 Graft Versus Host Disease (GVHD) - Pipeline by Nohla Therapeutics Inc 158 Graft Versus Host Disease (GVHD) - Pipeline by Novartis AG 158 Graft Versus Host Disease (GVHD) - Pipeline by OncoImmune Inc 159 Graft Versus Host Disease (GVHD) - Pipeline by OSE Immunotherapeutics 159 Graft Versus Host Disease (GVHD) - Pipeline by Pfizer Inc 160 Graft Versus Host Disease (GVHD) - Pipeline by Pharmicell Co Ltd 160 Graft Versus Host Disease (GVHD) - Pipeline by REGiMMUNE Corp 161 Graft Versus Host Disease (GVHD) - Pipeline by Sanofi 161 Graft Versus Host Disease (GVHD) - Pipeline by Sarepta Therapeutics Inc 162 Graft Versus Host Disease (GVHD) - Pipeline by Seattle Genetics Inc 162 Graft Versus Host Disease (GVHD) - Pipeline by Seres Therapeutics Inc 163 Graft Versus Host Disease (GVHD) - Pipeline by Sigmoid Pharma Ltd 163 Graft Versus Host Disease (GVHD) - Pipeline by Synedgen Inc 164 Graft Versus Host Disease (GVHD) - Pipeline by Takeda Pharmaceutical Company Ltd 164 Graft Versus Host Disease (GVHD) - Pipeline by Targazyme Inc 165 Graft Versus Host Disease (GVHD) - Pipeline by TC BioPharm Ltd 165 Graft Versus Host Disease (GVHD) - Pipeline by TxCell SA 166 Graft Versus Host Disease (GVHD) - Pipeline by United BioPharma Inc 166 Graft Versus Host Disease (GVHD) - Pipeline by Vault Pharma Inc 167 Graft Versus Host Disease (GVHD) - Pipeline by VBI Vaccines Inc 167 Graft Versus Host Disease (GVHD) - Pipeline by Xenikos BV 168 Graft Versus Host Disease (GVHD) - Pipeline by XL-protein GmbH 168 Graft Versus Host Disease (GVHD) - Pipeline by ZIOPHARM Oncology Inc 169 Liver Transplant Rejection - Pipeline by Astellas Pharma Inc 170 Liver Transplant Rejection - Pipeline by Biogen Inc 170 Liver Transplant Rejection - Pipeline by Conatus Pharmaceuticals Inc 171 Liver Transplant Rejection - Pipeline by Dompe Farmaceutici SpA 171 Liver Transplant Rejection - Pipeline by Novartis AG 172 Liver Transplant Rejection - Pipeline by RedHill Biopharma Ltd 172 Kidney Transplant Rejection - Pipeline by Amgen Inc 173 Kidney Transplant Rejection - Pipeline by Angion Biomedica Corp 173 Kidney Transplant Rejection - Pipeline by Apellis Pharmaceuticals Inc 174 Kidney Transplant Rejection - Pipeline by Astellas Pharma Inc 174 Kidney Transplant Rejection - Pipeline by Biogen Inc 175 Kidney Transplant Rejection - Pipeline by Catalyst Biosciences Inc 175 Kidney Transplant Rejection - Pipeline by Corline Biomedical AB 176 Kidney Transplant Rejection - Pipeline by CSL Ltd 176 Kidney Transplant Rejection - Pipeline by GlaxoSmithKline Plc 177 Kidney Transplant Rejection - Pipeline by Grifols SA 177 Kidney Transplant Rejection - Pipeline by Hansa Medical AB 178 Kidney Transplant Rejection - Pipeline by Kyowa Hakko Kirin Co Ltd 178 Kidney Transplant Rejection - Pipeline by Magnus Life Ltd 179 Kidney Transplant Rejection - Pipeline by Noorik Biopharmaceuticals AG 179 Kidney Transplant Rejection - Pipeline by Novartis AG 180 Kidney Transplant Rejection - Pipeline by Opsona Therapeutics Ltd 180 Kidney Transplant Rejection - Pipeline by OSE Immunotherapeutics 181 Kidney Transplant Rejection - Pipeline by Pharmicell Co Ltd 181 Kidney Transplant Rejection - Pipeline by Pharming Group NV 182 Kidney Transplant Rejection - Pipeline by Prolong Pharmaceuticals LLC 182 Kidney Transplant Rejection - Pipeline by Quark Pharmaceuticals Inc 183 Kidney Transplant Rejection - Pipeline by Shire Plc 183 Kidney Transplant Rejection - Pipeline by Tiziana Life Sciences Plc 184 Lung Transplant Rejection - Pipeline by Apeptico Forschung und Entwicklung GmbH 185 Lung Transplant Rejection - Pipeline by Dompe Farmaceutici SpA 185 Lung Transplant Rejection - Pipeline by Kamada Ltd 186 Lung Transplant Rejection - Pipeline by Novartis AG 186 Lung Transplant Rejection - Pipeline by Quark Pharmaceuticals Inc 187 Heart Transplant Rejection - Pipeline by Astellas Pharma Inc 187 Heart Transplant Rejection - Pipeline by Heat Biologics Inc 188 Heart Transplant Rejection - Pipeline by Noxxon Pharma AG 188 Bone Marrow Transplant Rejection - Dormant Projects 189 Graft Versus Host Disease (GVHD) - Dormant Projects 192 Liver Transplant Rejection - Dormant Projects 195 Kidney Transplant Rejection - Dormant Projects 196 Lung Transplant Rejection - Dormant Projects 198 Heart Transplant Rejection - Dormant Projects 198 Bone Marrow Transplant Rejection - Discontinued Products 199 Graft Versus Host Disease (GVHD) - Discontinued Products 199 Liver Transplant Rejection - Discontinued Products 200 Kidney Transplant Rejection - Discontinued Products 200 List of Figures Number of Products under Development for Bone Marrow Transplant Rejection 16 Number of Products under Development by Companies, Bone Marrow Transplant Rejection 17 Number of Products under Development by Universities/Institutes, Bone Marrow Transplant Rejection 20 Number of Products under Development for Graft Versus Host Disease (GVHD) 27 Number of Products under Development by Companies, Graft Versus Host Disease (GVHD) 28 Number of Products under Development by Universities/Institutes, Graft Versus Host Disease (GVHD) 31 Number of Products under Development for Liver Transplant Rejection 38 Number of Products under Development by Companies, Liver Transplant Rejection 39 Number of Products under Development by Universities/Institutes, Liver Transplant Rejection 40 Number of Products under Development for Kidney Transplant Rejection 42 Number of Products under Development by Companies, Kidney Transplant Rejection 43 Number of Products under Development by Universities/Institutes, Kidney Transplant Rejection 45 Number of Products under Development for Lung Transplant Rejection 48 Number of Products under Development by Companies, Lung Transplant Rejection 49 Number of Products by Top 10 Targets, Bone Marrow Transplant Rejection 52 Number of Products by Stage and Top 10 Targets, Bone Marrow Transplant Rejection 52 Number of Products by Top 10 Mechanism of Actions, Bone Marrow Transplant Rejection 55 Number of Products by Stage and Top 10 Mechanism of Actions, Bone Marrow Transplant Rejection 55 Number of Products by Routes of Administration, Bone Marrow Transplant Rejection 58 Number of Products by Stage and Routes of Administration, Bone Marrow Transplant Rejection 58 Number of Products by Top 10 Molecule Types, Bone Marrow Transplant Rejection 60 Number of Products by Stage and Top 10 Molecule Types, Bone Marrow Transplant Rejection 60 Number of Products by Top 10 Targets, Graft Versus Host Disease (GVHD) 62 Number of Products by Stage and Top 10 Targets, Graft Versus Host Disease (GVHD) 62 Number of Products by Top 10 Mechanism of Actions, Graft Versus Host Disease (GVHD) 65 Number of Products by Stage and Top 10 Mechanism of Actions, Graft Versus Host Disease (GVHD) 65 Number of Products by Routes of Administration, Graft Versus Host Disease (GVHD) 68 Number of Products by Stage and Routes of Administration, Graft Versus Host Disease (GVHD) 68 Number of Products by Top 10 Molecule Types, Graft Versus Host Disease (GVHD) 70 Number of Products by Stage and Top 10 Molecule Types, Graft Versus Host Disease (GVHD) 70 Number of Products by Top 10 Targets, Liver Transplant Rejection 72 Number of Products by Stage and Top 10 Targets, Liver Transplant Rejection 72 Number of Products by Top 10 Mechanism of Actions, Liver Transplant Rejection 74 Number of Products by Stage and Top 10 Mechanism of Actions, Liver Transplant Rejection 74 Number of Products by Routes of Administration, Liver Transplant Rejection 76 Number of Products by Stage and Routes of Administration, Liver Transplant Rejection 76 Number of Products by Molecule Types, Liver Transplant Rejection 78 Number of Products by Stage and Molecule Types, Liver Transplant Rejection 78 Number of Products by Top 10 Targets, Kidney Transplant Rejection 80 Number of Products by Stage and Top 10 Targets, Kidney Transplant Rejection 80 Number of Products by Top 10 Mechanism of Actions, Kidney Transplant Rejection 82 Number of Products by Stage and Top 10 Mechanism of Actions, Kidney Transplant Rejection 82 Number of Products by Routes of Administration, Kidney Transplant Rejection 84 Number of Products by Stage and Routes of Administration, Kidney Transplant Rejection 84 Number of Products by Top 10 Molecule Types, Kidney Transplant Rejection 86 Number of Products by Stage and Top 10 Molecule Types, Kidney Transplant Rejection 86 Number of Products by Targets, Lung Transplant Rejection 88 Number of Products by Stage and Targets, Lung Transplant Rejection 88 Number of Products by Top 10 Mechanism of Actions, Lung Transplant Rejection 90 Number of Products by Stage and Top 10 Mechanism of Actions, Lung Transplant Rejection 90 Number of Products by Routes of Administration, Lung Transplant Rejection 92 Number of Products by Stage and Routes of Administration, Lung Transplant Rejection 92 Number of Products by Molecule Types, Lung Transplant Rejection 94 Number of Products by Stage and Molecule Types, Lung Transplant Rejection 94 Number of Products by Targets, Heart Transplant Rejection 96 Number of Products by Stage and Targets, Heart Transplant Rejection 96 Number of Products by Mechanism of Actions, Heart Transplant Rejection 98 Number of Products by Stage and Mechanism of Actions, Heart Transplant Rejection 98 Number of Products by Routes of Administration, Heart Transplant Rejection 100 Number of Products by Stage and Routes of Administration, Heart Transplant Rejection 100 Number of Products by Molecule Types, Heart Transplant Rejection 102 Number of Products by Stage and Routes of Administration, Heart Transplant Rejection 102